Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Type 2 Diabetes Group: Placebo + Metformin	141
Overall Study	STARTED	Type 2 Diabetes Group: Colesevelam + Metformin	145
Overall Study	STARTED	Pre-diabetic Group: Placebo	108
Overall Study	STARTED	Pre-diabetic Group: Colesevelam	108
Overall Study	COMPLETED	Type 2 Diabetes Group: Placebo + Metformin	120
Overall Study	COMPLETED	Type 2 Diabetes Group: Colesevelam + Metformin	124
Overall Study	COMPLETED	Pre-diabetic Group: Placebo	92
Overall Study	COMPLETED	Pre-diabetic Group: Colesevelam	96
Overall Study	NOT COMPLETED	Type 2 Diabetes Group: Placebo + Metformin	21
Overall Study	NOT COMPLETED	Type 2 Diabetes Group: Colesevelam + Metformin	21
Overall Study	NOT COMPLETED	Pre-diabetic Group: Placebo	16
Overall Study	NOT COMPLETED	Pre-diabetic Group: Colesevelam	12

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00570739/flow